This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
Freelance translator and/or interpreter, Verified site user
Data security
This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.
Affiliations
This person is not affiliated with any business or Blue Board record at ProZ.com.
English to Slovenian: Cardioprotective Haemodialysis General field: Medical
Source text - English Cardioprotective Haemodialysis
FX classix
High-Flux Dialysis for Improved Survival
Protect your Patient
Cardioprotective Haemodialysis
The reduction of risk factors for cardiovascular diseases (CVD) is core to the development of dialysis systems and products at Fresenius Medical Care. Outstanding cardioprotection must be reflected in all levels of product development and application.
Wide-ranging cardioprotection
There have been tremendous improvements in the quality and efficacy of haemodialysis (HD) therapy in recent years. Despite this, cardiovascular diseases (CVD) remain the leading cause of death for patients with end-stage renal disease (ESRD). Moreover, overall and cardiovascular mortality is markedly greater in ESRD patients than in the general population. This is why we put Cardioprotective Haemodialysis on the SPOT. A comprehensive approach that includes services, products and therapies is needed to achieve the best therapeutic performance – meaning improved clinical outcomes and better quality of life, enhanced control of therapy costs, and simpler, safer handling.
Translation - Slovenian Hemodializa s kardioprotektivnim učinkom
FX classix
Visokopretočna dializa za izboljšane možnosti preživetja
Zaščitite svoje bolnike
Hemodializa s kardioprotektivnim učinkom
Zmanjševanje dejavnikov tveganja za nastanek srčno-žilne bolezni je ključnega pomena za razvoj dializnih sistemov pri skupini Fresenius Medical Care. Vse ravni razvoja izdelkov in njihove uporabe morajo odražati izjemen kardioprotektiven učinek.
Širok kardioprotektiven učinek
V zadnjih letih sta se kakovost in učinkovitost zdravljenja s hemodializo izjemno izboljšali. Kljub temu srčno-žilne bolezni ostajajo glavni vzrok smrti pri bolnikih s končno ledvično odpovedjo. Še več, celokupna umrljivost in umrljivost zaradi srčno-žilnih bolezni je pri bolnikih s končno ledvično odpovedjo bistveno višja kot pri splošni populaciji. Zato bomo hemodializo s kardioprotektivnim učinkom postavili v SREDIŠČE. Za zagotavljanje najboljših učinkov zdravljenja, tj. izboljšani klinični rezultati, boljša kakovost življenja, večji nadzor nad stroški zdravljenja ter preprostejše in varnejše ravnanje, je potreben celostni pristop, ki vključuje storitve, izdelke in metode zdravljenja.
More
Less
Translation education
Graduate diploma - University of Maribor, Faculty of Arts
Experience
Years of experience: 19. Registered at ProZ.com: Jan 2013.